+44 115 7870500
DevelRx Logo
HomeTeam
Services
Research & Candidate SelectionDrug DevelopmentRegistrationMarketing
News & EventsPartnersContact

Poster presentations - Binge-Eating Disorder

Drug Abuse and DependenceADHDBinge-Eating DisorderPsychiatric and Neurological DisordersObesity and Metabolic Disorders

Heal DJ, Vickers SP, Hopkins SC, Koblan KS. Investigation of the effects of dasotraline in a validated rat model of binge-eating disorder. American College of Neuropsychopharmacology Meeting, Dec 2018.

Hutson PH, Vickers SP, Goddard S, Hallam M, Brammer RJ, Heal DJ. Preclinical evidence to demonstrate that lisdexamfetamine prevents impulsivity in binge-eating. American College of Neuropsychopharmacology Meeting, Dec 2015.

Tarazi FI, Choi YK, Gosden J, Heal DJ, Hutson PH. Reduced expression of GAD65/67 mRNA and dopamine D1 and D2 receptors in binge-eating rats. American College of Neuropsychopharmacology Meeting, Dec 2015.

Heal DJ, Hutson PH, Goddard S, Brammer RJ, Vickers SP. Binge-eating rats exhibit compulsive and perseverative behaviour in a novel food reward/punished responding model. Society for Neurosciences Congress, Oct 2015.

Vickers SP, Hutson PH, Goddard S, Hallam M, Brammer RJ, Heal DJ. Binge-eating rats show marked impulsivity in a delay discounting test. Society for Neurosciences Congress, Oct 2015.

Hutson P, Rowley HL Kulkarni RS, Heal DJ. Lisdexamfetamine-induced suppression of binge eating in rats is attenuated by the α1 adrenoceptor antagonist, prazosin. American College of Neuropsychopharmacology Meeting, Dec 2014.

Heal DJ, Vickers SP, Hackett D, Hutson PH. Effect of lisdexamfetamine in a rat model of binge-eating disorder. European College of Neuropsychopharmacology, Oct 2013.

DevelRx Logo

Biocity,

Pennyfoot Street,

Nottingham,

Nottinghamshire,

NG1 1GF

Legal

Cookie PolicyPrivacy PolicyTerms & Conditions
inform@develrx.com

Registered in England and Wales

Company number: 12028847